An increasingly health-conscious China still has an appetite for foreign vitamin and supplements brands, despite growing domestic competition. RedFern Digital spoke to Benji Lamb from British supplement brand Vitabiotics about how British brands can tailor their offering to maximise success in China Benji Lamb is the director of China and South Asia at Vitabiotics, the UK’s number one vitamin and supplements brand. China is one of Vitabiotics’ top three markets …
Category:
Healthcare
AstraZeneca’s new Shanghai R&D centre is helping to make the city one of the world’s most high-tech biopharmaceutical hubs At the opening ceremony of International Biopharma Industry Week Shanghai on 11 October, CEO of AstraZeneca, Pascal Soriot, announced the inauguration of its newly-upgraded global R&D centre. As reported by Yicai Global, at the ceremony Soriot said that the new centre has introduced “state-of-the-art technologies and expanded our R&D team to …
As China’s ageing population becomes more of an issue, products that offer solutions to such problems are becoming a hot topic at events such as the upcoming Design Intelligence Awards — applications for which close on 9 July — writes Robynne Tindall The results of China’s 2020 census showed that the population is ageing rapidly. There are now 264 million people over the age of 65 in China, accounting for …
From an innovative new tampon to the world’s first 3D printed bionic arm, UK companies are serial winners at the Design Intelligence Awards (DIA) – yet another reason to enter the awards before applications close on July 9, writes Robynne Tindall In 2020, UK applicants to the DIA were awarded more funding than Japan, India and Germany combined. UK innovators topped the international league tables outside China, with 18 finalists …
After much initial scepticism about telemedicine, the Covid-19 outbreak has brought the format front and centre. Mainstream adoption, private investment and government support means it’s here to stay, writes Tom Pattinson The Covid-19 outbreak that spread around China at the start of the year – and the subsequent lockdown that kept people away from overcrowded hospitals – shifted the traditional Chinese notion of what healthcare is. Unable to get to …
Getting healthcare in China can be complex, depending on employment, location, insurance-type and many other variables. Hai Feng of Peking University gives a comprehensive overview of how China’s healthcare system actually works I am sick. What do I do? Public insurance and steps toward universal healthcare Approximately 95% of China’s population is covered by a public insurance programme. These are made up of voluntary public insurance and mandatory public …
The Covid outbreak has caused every nation to look at its healthcare systems. China’s already complex system needs simplifying and to spend more on soft skills, writes Tom Pattinson China’s healthcare system is complex. As we can see from our recent article produced by the Commonwealth fund, the quality of care people receive depends on a patient’s type of job, region of residence, and income bracket. It is a far …
PROFESSOR MONIQUE SIMMONDS, DEPUTY DIRECTOR OF SCIENCE AT THE ROYAL BOTANIC GARDENS AT KEW, TALKS TO GABRIELLE JAFFE ABOUT THE OPPORTUNITIES AND CHALLENGES OF TCM AND WHAT HER ORGANISATION IS DOING TO MAKE IT SAFER FOR USERS AND BETTER FOR THE ENVIRONMENT. The Traditional Chinese Medicine (TCM) industry is worth over £30 billion and is only set to grow as interest increases worldwide and the Chinese government heavily pushes …
Beijing aims to eradicate rural poverty this year – but challenges lie ahead, writes Charlotte Middlehurst When four siblings, aged between six and fourteen years old, committed joint suicide by drinking fertiliser in the village of Cizhou, south China, in 2015, the nation was horrified. In a note, the eldest boy wrote that he had “dreamed of death,” an end to the years of suffering and neglect they had endured. …
In 2019, AstraZeneca China launched the I-Campus – a health-tech incubator – in collaboration with the Wuxi local government. Here Michael Lai, General Manager of AstraZeneca China, talks more about the project and China’s growing healthcare sector What is the I-Campus exactly? I·Campus is a one-stop incubation platform for life science innovation companies. It will land, incubate, accelerate, and scale up both domestic and overseas life science companies with support …